Copperwynd Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Buy |
1,084
+81
| +8% | +$42.5K | 0.14% | 110 |
|
|
2025
Q1 | $636K | Buy |
1,003
+283
| +39% | +$180K | 0.18% | 106 |
|
|
2024
Q4 | $513K | Sell |
720
-78
| -10% | -$55.6K | 0.14% | 101 |
|
|
2024
Q3 | $839K | Buy |
798
+10
| +1% | +$10.5K | 0.25% | 78 |
|
|
2024
Q2 | $851K | Buy |
788
+35
| +5% | +$37.8K | 0.28% | 62 |
|
|
2024
Q1 | $725K | Sell |
753
-12
| -2% | -$11.6K | 0.26% | 76 |
|
|
2023
Q4 | $672K | Sell |
765
-27
| -3% | -$23.7K | 0.27% | 69 |
|
|
2023
Q3 | $652K | Sell |
792
-28
| -3% | -$23.1K | 0.31% | 58 |
|
|
2023
Q2 | $590K | Sell |
820
-2
| -0.2% | -$1.44K | 0.27% | 83 |
|
|
2023
Q1 | $676K | Buy |
822
+12
| +1% | +$9.87K | 0.35% | 62 |
|
|
2022
Q4 | $584K | Sell |
810
-14
| -2% | -$10.1K | 0.33% | 70 |
|
|
2022
Q3 | $568K | Sell |
824
-38
| -4% | -$26.2K | 0.33% | 65 |
|
|
2022
Q2 | $510K | Sell |
862
-12
| -1% | -$7.1K | 0.3% | 80 |
|
|
2022
Q1 | $610K | Buy |
874
+168
| +24% | +$117K | 0.25% | 86 |
|
|
2021
Q4 | $446K | Buy |
706
+2
| +0.3% | +$1.26K | 0.17% | 101 |
|
|
2021
Q3 | $426K | Buy |
+704
| New | +$426K | 0.18% | 104 |
|
|
2021
Q2 | – | Sell |
-920
| Closed | -$435K | – | 127 |
|
|
2021
Q1 | $435K | Buy |
920
+298
| +48% | +$141K | 0.2% | 100 |
|
|
2020
Q4 | $300K | Buy |
622
+149
| +32% | +$71.9K | 0.14% | 108 |
|
|
2020
Q3 | $265K | Buy |
473
+110
| +30% | +$61.6K | 0.14% | 105 |
|
|
2020
Q2 | $226K | Buy |
+363
| New | +$226K | 0.13% | 95 |
|